Search results
Dr. Kenneth Anderson is the Kraft Family Professor of Medicine at Harvard Medical School, as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. After graduating from Johns Hopkins Medical School, he trained in internal medicine at Johns Hopkins Hospital ...
Sep 8, 2022 · In multiple myeloma, bispecific antibodies are among the most promising new treatments on the horizon, says Ken Anderson, MD, director of the Jerome Lipper Multiple Myeloma Center and the LeBow Institute for Myeloma Therapeutics at Dana-Farber. Leena Gandhi, MD, PhD (right), in conversation with Nurse Practitioner Mee-young Lee, MSN, ANP-BC.
Ken Anderson, M.D. is a Co-founder of C4 Therapeutics and has served as a member of the Board of Directors since December 2015. Dr. Anderson is the Kraft Family Professor of Medicine at Harvard Medical School as well as Director of the Jerome Lipper Multiple Myeloma Center and Lebow Institute for Myeloma Therapeutics at the Dana-Farber Cancer Institute.
Ken Anderson, MD 05:38 In myeloma, there is one clone of cells that produces one abnormal clone of protein. Ken Shulman 05:46 That's Ken Anderson. He directs the Jerome Lipper Multiple Myeloma Center and Lebow Institute for Myeloma Therapeutics at Dana-Farber. Ken Anderson, MD 05:55
Apr 19, 2022 · April 19, 2022. Receive Dana-Farber's e-newsletter, Momentum, to learn of advances in cancer research and care, current clinical trials, and upcoming CME programs. Sign up today! Trace the remarkable growth and development of medical oncology at Dana-Farber — from its early roots to today's mission-driven commitment to excellence in research ...
Aug 4, 2020 · The drug went into trials after laboratory work by Dana-Farber’s Yu-Tzu Tai, PhD, and Kenneth Anderson, MD, showed it was active against myeloma cells. In the clinical trial, the three-drug combination lowered the risk that the disease would progress by 40%, compared to pomalidomide and dexamethasone alone. Paul Richardson, MD, Yu-Tzu Tai ...
Jan 24, 2024 · The Dana-Farber Cancer Institute Craig F. Walker / The Boston Globe via Getty Images. More than 50 ... COO William Hahn and senior researchers Irene Ghobrial and Kenneth Anderson, ...
